Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1Phase 1 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Lymphoma 4Prostatic Neoplasms 2Lymphoma, Follicular 2Lymphoma, B-Cell 2Recurrence 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Ovarian Neoplasms 1Multiple Myeloma 1Lymphoma, T-Cell, Peripheral 1Lymphoma, T-Cell 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, T-Cell 1Leukemia, Lymphoid 1Immunoblastic Lymphadenopathy 1Hodgkin Disease 1Advanced Cancer 1

Interventions

Bortezomib 9Cyclophosphamide 7tanespimycin 4fludarabine phosphate 4Vorinostat 4Paclitaxel 4Filgrastim 4Carboplatin 4fludarabine 3Peripheral Blood Stem Cell Transplantation 3Lenalidomide 3Irinotecan 3Everolimus 3Etoposide 3Doxorubicin 3Dasatinib 3Azacitidine 3sargramostim 2romidepsin 2laromustine 2ixabepilone 2entinostat 2belinostat 2Whole-Body Irradiation 2Vincristine 2Topotecan 2Tacrolimus 2Radiotherapy 2Prednisone 2Pharmacogenomic Testing 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Immunoblastic Lymphadenopathy × Prednisolone × Clear all
NCT00562068 2013-08-26

Alemtuzumab and Combination Chemotherapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Peripheral T-Cell Lymphoma

National Cancer Institute (NCI)

Phase 1 Unknown
30 enrolled
LymphoidOther hematologic neoplasm

Immunoblastic Lymphadenopathy, Lymphoma, Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡